Cargando…
Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo
BACKGROUND: The Democratic Republic of the Congo (DRC) changed its national policy for the treatment of severe malaria in both children and adults in 2012 from intravenous quinine to injectable artesunate. The country is now planning to deploy nationwide injectable artesunate as the preferred treatm...
Autores principales: | Ntuku, Henry M. T., Ferrari, Gianfrancesco, Burri, Christian, Tshefu, Antoinette K., Kalemwa, Didier M., Lengeler, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706670/ https://www.ncbi.nlm.nih.gov/pubmed/26747281 http://dx.doi.org/10.1186/s12936-015-1072-x |
Ejemplares similares
-
Delayed Anemia after Treatment with Injectable Artesunate in the Democratic Republic of the Congo: A Manageable Issue
por: Burri, Christian, et al.
Publicado: (2014) -
Identifying risk factors for Plasmodium infection and anaemia in Kinshasa, Democratic Republic of Congo
por: Ferrari, Giovanfrancesco, et al.
Publicado: (2016) -
A comprehensive risk map for malaria in Kinshasa, Democratic Republic of Congo
por: Ferrari, Giovanfrancesco, et al.
Publicado: (2012) -
A malaria risk map of Kinshasa, Democratic Republic of Congo
por: Ferrari, Giovanfrancesco, et al.
Publicado: (2016) -
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study
por: Ferrari, Giovanfrancesco, et al.
Publicado: (2015)